Clinical Trial Update: Solifenacin Compared to Clonidine for Reducing Hot Flashes Among Breast Cancer Patients [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial comparing solifenacin to clonidine to reduce hot flashes in breast cancer patients, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Catapres (clonidine)
• Vesicare (solifenacin succinate)

Snippet

Sponsor: University of Arkansas | Conditions: Hot Flashes, Breast Cancer | Phase 2 | Status: RECRUITING